Japan’s Ajinomoto to acquire US-based CDMO Forge Biologics for $620m
The acquisition of Forge Biologics is expected to expand Ajinomoto’s AAV and plasmid gene therapy manufacturing capabilities, while…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
14 Nov 23
The acquisition of Forge Biologics is expected to expand Ajinomoto’s AAV and plasmid gene therapy manufacturing capabilities, while…
24 Oct 23
As per the multi-year agreement, Samsung Biologics will offer Kurma Partners' portfolio companies with customised services for chemistry,…
27 Sep 23
The DP facility is equipped with an automatic vial washing, sterilizing, filling and capping line, which can support…
10 Aug 23
As part of the expansion of the Milan site, AGC Biologics has added five suspension single-use bioreactors, including…
07 Jun 23
Scheduled to open in July 2023, the new regional commercial office located in Minato, Tokyo, will be part…
05 May 23
Under the terms of the agreement, Novocol Pharma will provide fill-finish and packaging for vaccines manufactured at Moderna’s…
20 Mar 23
The contract development and manufacturing organisation (CDMO) intends to build Plant 5 at Bio Campus II, with a…
15 Mar 23
The Rockford hub will have product testing capability, top-load cartoning technology, and injector and pen assembly equipment
16 Feb 23
The partnership will use Charles River’s eXpDNA plasmid platform and experience at its plasmid DNA manufacturing centre of…
03 Nov 22
The new facility will support the North American growth of Kinder Bueno, which Ferrero launched in the market in…